I've added to Aphria on the downslope, but didn't think they were heading back to the $3's. Geeezzz
They may post north of $180M in fiscal Q1 to be released mid-Oct. Hopefully they don't have a sequential QoQ decline. If so, they might dip to the low $3s or even $2s.
They already posted $90M last Q from their German subsidiary, CC Pharma. Aphria is clearly the LP leader in Canada and Internationally.
They got a feather in the cap because they walked away from the ACB deal.
We're all hoping for the USA acquisition announcement to generate enthusiasm before the Q.